Microbiome And Health Insights

Today, I’m thrilled to share what I believe is the biggest breakthrough in microbiome science for a decade. Nature Magazine, the world's most influential scientific journal, has just published a scientific paper by ZOE's scientists, establishing the first reliable, repeatable, global way to measure the health of an individual’s gut microbiome. It represents the culmination of eight years of work at ZOE. Scientists have been trying to solve this puzzle for more than 20 years, right back to when they first discovered how important our gut microbes are for our health. It’s been achieved only because more than 34,000 ZOE members took part in this research. We’ve known for a long time that the microbiome is linked to cholesterol, inflammation, blood sugar control and even how we store fat. But we’ve never had a clear, evidence-based way to measure how healthy a microbiome actually is. This analysis finally delivers it, revealing a global ranking of microbes that works across populations, diets and environments. The insights are remarkable. Among the top 50 “good microbes” linked with better health, 22 were completely unknown to science until today, and most of the others have never been successfully grown in a lab. We also discovered clear links between these good microbes and health outcomes: healthy individuals carry around 3.6 more of these beneficial species, and people at a healthy weight carry about 5.2 more than those living with obesity. We also found a strong connection to diet. People eating healthier diets consistently have microbiomes that score better on this ranking. What we eat shapes our gut health, and now we can measure this relationship with unprecedented clarity. ZOE was created to enable microbiome research at a scale that traditional science has been unable to fund, and use this research to create actionable advice that can transform our gut health. This is a major milestone in that journey. I’m delighted to say that as a result, this breakthrough science is immediately available for the public to investigate their own microbiome through ZOE’s new Gut Health Test in the UK, and this is coming soon in the US. You can now receive not only a reliable measurement of how healthy your microbiome is as you change their diet, but also discover the health of clusters of gut microbes in your gut affecting metabolism, inflammation and more. To all our amazing ZOE members who have participated in our science: you made this possible. You are transforming our understanding of the microbiome. Thank you so much. I hope you feel as proud and excited as I do. I should note that your research is now published in Nature, which is the ultimate scientific accolade, and you can definitely brag about that with your friends! If you think this science could help others understand their health, I’d love for you to share it. You’ll find links to more details from our findings and access to the paper in the comments.

One of the most overlooked stroke risk factors isn't in your arteries. It's in your gums. Researchers analyzing blood clots from stroke patients found oral bacteria DNA within the blockages. Not just present. Biologically capable of contributing to the blockage itself. 𝗛𝗢𝗪 𝗚𝗨𝗠 𝗗𝗜𝗦𝗘𝗔𝗦𝗘 𝗥𝗘𝗔𝗖𝗛𝗘𝗦 𝗧𝗛𝗘 𝗕𝗥𝗔𝗜𝗡 This isn't just correlation. It's a biologically plausible pathway, backed by human and experimental evidence. ↳ P. gingivalis (a key gum disease bacterium) enters the bloodstream when gums bleed ↳ Triggers systemic inflammation ↳ Damages arterial walls ↳ Accelerates plaque formation ↳ Plaques block blood flow → stroke Bleeding gums aren't just a local problem. They're a systemic vascular signal. 𝗧𝗛𝗘 𝗘𝗩𝗜𝗗𝗘𝗡𝗖𝗘 𝗛𝘂𝗺𝗮𝗻 𝘁𝗶𝘀𝘀𝘂𝗲 𝗽𝗿𝗼𝗼𝗳: ↳ Gingipain enzymes from P. gingivalis were identified in human brain tissue (Science Advances, 2019) 𝗖𝗹𝗼𝘁-𝗹𝗲𝘃𝗲𝗹 𝗽𝗿𝗼𝗼𝗳: ↳ Oral bacteria DNA detected directly inside blood clots from ischemic stroke patients 𝗥𝗶𝘀𝗸 𝗺𝗮𝗴𝗻𝗶𝘁𝘂𝗱𝗲: ↳ Periodontitis linked to 50-70% higher stroke risk, even after adjusting for smoking, diabetes, and blood pressure This suggests gum disease doesn't just travel alongside stroke risk. It likely contributes to it in at least some patients. 𝗧𝗛𝗘 𝗠.𝗢.𝗨.𝗧.𝗛. 𝗙𝗥𝗔𝗠𝗘𝗪𝗢𝗥𝗞 𝗠 — 𝗠𝗼𝗻𝗶𝘁𝗼𝗿 𝗯𝗹𝗲𝗲𝗱𝗶𝗻𝗴 ↳ Bleeding gums increase the chance oral bacteria enter your bloodstream ↳ Track which areas bleed and address them 𝗢 — 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝗯𝗿𝘂𝘀𝗵𝗶𝗻𝗴 ↳ Electric toothbrush, 2 minutes, twice daily ↳ 45-degree angle at the gumline 𝗨 — 𝗨𝗻𝗱𝗲𝗿𝗻𝗲𝗮𝘁𝗵 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 ↳ Floss daily ↳ Periodontal bacteria thrive where brushes can't reach 𝗧 — 𝗧𝗿𝗲𝗮𝘁 𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗲𝗮𝗿𝗹𝘆 ↳ Bleeding beyond 2 weeks = dental review ↳ Don't wait for pain 𝗛 — 𝗛𝗮𝗹𝗳-𝘆𝗲𝗮𝗿𝗹𝘆 𝗰𝗹𝗲𝗮𝗻𝗶𝗻𝗴𝘀 ↳ Every 6 months routinely ↳ High cardiovascular risk: every 3-4 months 𝗪𝗛𝗔𝗧'𝗦 𝗖𝗛𝗔𝗡𝗚𝗜𝗡𝗚 𝗜𝗡 𝗠𝗘𝗗𝗜𝗖𝗜𝗡𝗘 Some cardiology and stroke teams now ask about oral health during cardiovascular risk assessments. ↳ Basic periodontal screening for high-risk patients ↳ Earlier treatment of gum inflammation ↳ Growing recognition that mouth health influences vascular health The goal isn't perfect teeth. It's reducing chronic inflammation at the source before it spreads downstream. Stroke prevention isn't just about cholesterol numbers. It's understanding how inflammation in one system amplifies disease in another. 💾 Save this for the next time you skip flossing because you're too tired ➕ Follow Dr Tim Patel for stories that turn hard science into action.

One twin watches her body fail while her identical sister stays perfectly healthy. Scientists just discovered the difference lives in their gut. Two bacteria turning the brain against itself. Think about that. German researchers recruited 81 pairs of identical twins where only one twin had MS—stripping away genetic confusion to expose what really causes MS. They discovered over 50 bacterial differences between affected and unaffected twins, with Eisenbergiella tayi and Lachnoclostridium species standing out as potential MS triggers. Traditional MS Reality: ↳ 2.8 million people affected worldwide ↳ Cause labeled "multifactorial mystery" ↳ Immune suppressants manage symptoms ↳ Progressive disability often inevitable The Microbiome Discovery: ↳ Specific bacteria enriched in MS twins ↳ Transplanted gut microbes trigger disease in mice ↳ Female mice particularly susceptible ↳ Direct gut-brain-immune connection proven But here's what grabbed me: When researchers transplanted gut bacteria from MS twins into germ-free mice, the animals developed MS-like disease. Not from genetics. Not from environment. From microbes alone. The bacteria from healthy twins? Protected the mice. Even more striking: Eisenbergiella tayi, barely detectable in human samples, became dominant in sick mice. A minor player in our gut turning the brain against itself. What changes everything: ↳ MS risk potentially measurable through stool samples ↳ Targeted antibiotics or bacteriophages possible ↳ Precision probiotics to outcompete harmful strains ↳ Prevention before symptoms, not just management The Multiplication Effect: 1 microbiome test = early risk detection 10 targeted interventions = personalized prevention 100 research centers refining = MS becoming preventable At scale = autoimmune diseases decoded through gut bacteria For decades, families watched one twin deteriorate while the other stayed healthy, wondering why their identical biology diverged. Now we know: the difference might be microscopic residents in their intestines. We spent 150 years treating MS as an inevitable brain disease. Now it might be a treatable gut imbalance. Because when identical DNA produces different diseases based on gut bacteria, you realise: The code for MS isn't just written in our genes. It's growing in our gut. Follow me, Dr. Martha Boeckenfeld for innovations where microscopic discoveries transform human health. ♻️ Share if you believe the next medical revolution lives in our gut, not our pharmacy. Resource: Kleinewietfeld, M., et al. (2024). Specific gut bacteria from multiple sclerosis patients modulate human T cell function and exacerbate symptoms in a mouse model. Proceedings of the National Academy of Sciences, 121(48), e2419689122.

Your gut isn’t just digesting food… It’s running a biochemical factory that keeps you alive. Most people think the colon is just “where waste goes.” But this illustration shows something more: Your colon is one of the most underrated metabolic organs in the entire body. Inside this 5-foot stretch of tubing, billions of bacteria are: 🔥 Creating vitamins 🔥 Producing short-chain fatty acids (the fuel your colon cells run on) 🔥 Detoxifying harmful compounds 🔥 Breaking down proteins into neurotransmitter precursors 🔥 Regulating your immune system 🔥 Deciding whether you feel inflamed, bloated, focused, or foggy And all of it is happening silently, every hour of every day. Looking closer at what this one diagram reveals: 🔸 Fiber → SCFAs (butyrate, acetate, propionate) These molecules lower inflammation, feed colon cells, improve insulin sensitivity, and even influence mood. 🔸 Protein → amino acids → neurotransmitter precursors Yes, your gut bacteria help shape serotonin, dopamine, and even histamine levels. 🔸 Your colon detoxifies more than your liver gets credit for. Phenols, ammonia, indoles, cresol, skatole. Your microbes help neutralize them before they ever hit your bloodstream. 🔸 Gas, pH changes, mucus secretion, metal excretion, nutrient salvage; it all happens here. Your colon saves water, electrolytes, energy, and even rescues calories you would otherwise lose. 🔸 The final 135 grams of stool are only a fraction of the metabolic work happening behind the scenes. This is why gut health affects EVERYTHING: digestion, immunity, mental clarity, inflammation, skin, sleep, metabolism; all of it. Your gut isn’t a waste pipe. It’s an ecosystem, a chemical lab, and a second brain whispering instructions to the rest of your body. Source: Thieme’s Color Atlas of Physiology

My PhD will focus on something we still only partially understand: the molecular mechanisms linking the oral microbiome, the gut, and neurodegeneration. For years, the scientific and clinical conversation has been centred on the gut–brain axis, often overlooking a critical upstream component. The oral microbiome has largely remained at the margins of this discussion, despite growing evidence that it plays a far more central role than previously assumed. This recent review brings this into sharper focus by showing that oral dysbiosis is not confined to the oral cavity but can actively contribute to systemic and neural processes. Several periodontal pathogens are able to disseminate beyond their local environment, influencing immune regulation and promoting inflammatory cascades that extend to the brain. What is particularly striking is that these mechanisms converge on pathways we already recognise as central to neurodegenerative and neuropsychiatric disorders, including microglial activation, cytokine release, and protein misfolding processes associated with Alzheimer’s and Parkinson’s disease. This shifts the perspective from isolated associations to a more integrated biological framework. The oral microbiome is not simply an additional variable, but part of a continuous system that interacts with the gut, the immune system, and neuroendocrine pathways such as the HPA axis. These interactions form a network in which microbial ecosystems across different body sites contribute to a shared inflammatory and metabolic landscape. What becomes increasingly difficult to justify is the way we continue to approach these domains separately. Oral health, gut health, and brain health are still often treated as distinct areas, both in research and in clinical practice. Yet the biology suggests otherwise. These systems are interconnected, and their interactions may be key to understanding not only disease progression but also potential points of intervention. This is precisely where my work is directed: moving beyond descriptive associations to identify the molecular signals that link these microbial ecosystems to neuroinflammatory processes. The goal is not simply to confirm that a connection exists, but to understand how it operates, and whether it can be meaningfully targeted. If these mechanisms are clarified, oral dysbiosis may no longer be seen as a secondary feature or a coincidental finding, but as a modifiable contributor to neurodegeneration. That shift has significant implications, both for how we conceptualise these conditions and for how we approach prevention and intervention. We are still at an early stage in connecting these layers, but one conclusion is becoming increasingly clear. Brain health cannot be fully understood without considering the broader microbial systems that influence it. #parkinsondisease #oralmicrobiome #gutmicrobiome #neurodegeneration https://lnkd.in/echFjvad

🧠 𝗬𝗼𝘂𝗿 𝗺𝗼𝘂𝘁𝗵 𝗰𝗮𝗻 𝘄𝗮𝗿𝗻 𝘆𝗼𝘂 𝗯𝗲𝗳𝗼𝗿𝗲 𝘆𝗼𝘂𝗿 𝗯𝗿𝗮𝗶𝗻 𝗱𝗼𝗲𝘀. A new 21 year study of nearly 6,000 adults found that people with both gum disease (periodontitis) and untreated tooth decay had an 86% higher risk of ischemic stroke, compared with individuals with healthy mouths. Those with gum disease alone saw a 44% increased risk. Here’s what it really means for dental-professionals, patients and everyday life: Oral health isn’t just about “a nice smile” or “no cavities” it can be a window into systemic vascular health. Inflammation and bacterial load from gum disease + decay may travel beyond the mouth and increase vascular risk. Regular dental checks and effective tooth & gum care matter this isn’t optional if you want to move beyond “teeth only” and help patients protect their brain health. As a dentist & implantologist, I see it in practice: the same patient who neglects extractions, fillings or deep-cleaning may also present with silent vascular risks we don’t always talk about. So here’s a call to action I’d put in front of every patient: “We fix your smile, but we’re also safeguarding your brain, your circulation, your future.” 𝗠𝘆 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆: Let’s broaden the narrative. When I assess and plan implant or prosthetic treatments, I now also ask: “How’s your gum health? How many cavities are untreated? When was your last deep clean?” Because the mouth body connection is real. Let’s partner with physicians, neurologists and cardiologists more often help patients understand that “brushing + cleaning” isn’t just dental hygiene, it’s brain protection. #OralHealth #StrokePrevention #Dentistry #Implantology #PublicHealth

Gut bacterium may be helping breast tumors hide from the immune system. And it appears to do it through a metabolite. Researchers found that Enterocloster bolteae, a member of the Lachnospiraceae family, became progressively more abundant as breast tumors developed. Its rise was linked to higher levels of deoxycholic acid, a secondary bile acid produced through microbial metabolism. But the metabolite did not remain confined to the gut. Deoxycholic acid accumulated inside the tumors and activated the farnesoid X receptor, or FXR, in cancer cells. That activation triggered NF-κB signaling and increased production of interleukin-6. IL-6 then recruited immune cells that can suppress antitumor immunity, including granulocytic myeloid-derived suppressor cells and T helper 17 cells. The result was a tumor microenvironment that appeared more capable of protecting the cancer from immune attack. The pathway looked like this: Enterocloster bolteae → deoxycholic acid → tumor FXR activation → NF-κB signaling → IL-6 production → immunosuppressive immune-cell recruitment → breast cancer progression This is more than another study showing that cancer is “associated” with changes in the microbiome. It proposes a specific biological chain connecting a gut organism, a circulating microbial metabolite, a receptor inside the tumor and a measurable immune response. Even more importantly, blocking FXR or IL-6 signaling weakened these effects in the experimental models. That creates several potential intervention points. Not just the bacterium itself, but its metabolic output, the tumor receptor it activates and the downstream inflammatory signal. This does not mean that modifying the microbiome can currently prevent or treat breast cancer. But it strengthens a much bigger idea: The gut microbiome may influence cancer progression from a distance by producing molecules that reach the tumor and reshape its immune environment. The next generation of cancer therapeutics may not focus only on the tumor. It may also target the microbial chemistry helping the tumor survive.

Dietary fiber intake has declined globally, paralleled by rising incidence of inflammatory bowel disease (IBD), allergies, and autoimmune diseases. Chronic inflammation is central to immune-mediated disease, and fiber modulates the gut microbiome to influence inflammatory processes. The gut microbiota metabolize fiber into short-chain fatty acids (SCFAs), which act as pivotal mediators linking diet, microbes, and host physiology. High-fiber regimens, such as Mediterranean and plant-based diets, consistently increase microbiome diversity and enrich SCFA-producing taxa, supporting intestinal barrier function and immune regulation. In inflammatory diseases, higher fiber intake is associated with reduced inflammatory markers (e.g., CRP, MCP-1, IL-18, IL-33) and improved disease activity indices in UC/CD and murine models. Whole-diet high-fiber interventions generally yield larger microbiome and clinical benefits than fiber supplements; effects vary with dosage, fiber type, and intervention duration. SCFAs cross the blood–brain barrier, potentially influencing microglial maturation and neuroinflammation. Dietary fiber shapes the gut ecosystem and inflammatory health primarily through SCFA-mediated mechanisms; realizing its therapeutic potential requires clear, personalized dietary strategies and robust clinical trials. SOURCE: F. Zhang et al. (2022). "The Gut Microbiome: Linking Dietary Fiber to Inflammatory Diseases." Medicine In Microecology. doi: 10.1016/j.medmic.2022.100070.

A clinical trial published in Nature Medicine shows that poop transplant can impact the efficacy of immunotherapy in lung and skin cancers. #Mysummary Immunotherapy has been a game-changer, but it still fails in about half of patients. A new Phase 2 trial ("FMT-LUMINate") investigated whether combining Fecal Microbiota Transplants (FMT) with immunotherapy could bridge this gap for advanced Lung Cancer (NSCLC) and Skin Cancer (Melanoma). The results were very interesting: 🔹 In advanced lung cancer patients, 80% responded to the combination treatment (compared to the historical average of just 39-45%). In melanoma patients, 75% responded (compared to the usual 50-58%). But it seems that we have been looking at it all wrong!! 🔹 We previously assumed FMT worked by "planting" good bacteria from the donor. This study found the opposite. Success wasn't driven by what was added, but by what was removed. The transplant successfully "weeded out" harmful bacteria (specifically Enterocloster and Clostridium species) that the patients were already carrying. 🔹 These "bad" bacteria were producing chemical waste that acted like a sleeping pill for the immune system. Once the transplant displaced them, the immune cells "woke up" and attacked the tumor. This changes everything... truly. #Mythoughts Here, one might say, "We need to stop thinking about 'boosting' the microbiome with probiotics and start thinking about 'clearing' the gut of inhibitory bacteria to let cancer drugs work." However, the study also issued a vital safety warning. Donors with high levels of a bacterium called Prevotella caused severe heart inflammation in specific melanoma patients. This discovery shows that the microbiome is a complex organ. "One size fits all" does not apply, but if we can precisely match donors to patients, we could significantly improve survival rates for our most difficult cancers. HAPPY to hear your thoughts and stay POSITIVE! #Myinspiration "Discovery consists of seeing what everybody has seen and thinking what nobody has thought." – Albert Szent-Györgyi You can read the full paper here: https://lnkd.in/eiwMUxe5 #Immunotherapy #Microbiome #LungCancer #Melanoma #FMT #CancerResearch #pharma #biology #nature #science Nature Portfolio

In the first Project 100 episode of 2026, I sit down with Oral Medicine Specialist Professor Sue-Ching Yeoh. This conversation goes far beyond dentistry. A/Prof Yeoh explains how the mouth acts as an early warning system for systemic disease, including autoimmune conditions, cancer, HPV, and chronic inflammation. She breaks down what gum disease actually is, why bad breath is often a medical issue rather than a hygiene one, and how lifestyle, genetics, vaping, smoking, and social media trends are quietly damaging oral health. We also cover practical, no-nonsense insights most people never hear: • How to properly self-check your mouth • The truth about tongue cleaning, saltwater rinses, whitening, and sensitivity • What tooth wear reveals about stress, nerve health, and ageing • When cosmetic treatments help and when they mask deeper issues • Why early detection in oral health can be life-saving Listen now on Spotify: https://lnkd.in/eGHkfG23 Listen now on Apple Podcasts: https://lnkd.in/eUMnCjRx